Heery Christopher's Form 4 filing
Arcellx, Inc. (ACLX) · filed Feb 7, 2023
- Accession no.
- 0001209191-23-007471
- Filed
- Feb 7, 2023
- Trade date
- Feb 3, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $44.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Heery ChristopherCIK 0001789632 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2023 | Common Stock | MOption exerciseAcquired | +400 | $6.28 | +$2,512 | 400 | Direct | |
| Feb 3, 2023 | Common Stock | MOption exerciseAcquired | +855 | $15.00 | +$12,825 | 1,255 | Direct | |
| Feb 3, 2023 | Common Stock | SSaleDisposed | −1,255 | $35.11F2 | −$44,063.05 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2023 | Common Stock | MOption exerciseDisposed | −400 | $0.00 | $0 | 256,223 | Direct | |
| Feb 3, 2023 | Common Stock | MOption exerciseDisposed | −855 | $0.00 | $0 | 249,350 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 1,255 shares sold in the price range of $35.04 to $35.27 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.